PD-L1-IN-6 (Compound 16) targets STAT3, with a KD of 90.5 nmol/L, to inhibit the expression of PD-L1 in neutrophils. It enhances the antifungal immune response mediated by neutrophils and is effective when administered orally.
Formula:
C21H24Cl2O6S
Target:
PD-1/PD-L1,STAT
* VAT and and shipping costs not included. Errors and price changes excepted
